3,4-DHB—3,4-dihydroxybenzonate;

6-OHDA—6-hydroxydopamine;

α-syn—α-synuclein.

AAV—adeno-associated virus;

AD—Alzheimer’s disease;

AICD—APP intracellular domain;

ApoE—apolipoprotein E;

APP—amyloid precursor protein;

ARNT—aryl hydrocarbon receptor nuclear translocator—HIF-β subunit;

Aβ—amyloid-β;

BACE-1—beta-site APP-cleaving enzyme 1;

DA—dopamine;

DFO—deferoxamine;

EPO—erythropoietin;

FIH—FIH—asparaginyl hydroxylase;

GLUT 1—glucose transporter-1;

GLUT 3—glucose transporter-3;

HIF—hypoxia-inducible factor;

HO-1—heme oxygenase-1;

HRE—hypoxia-responsive elements, short DNA sequences within the gene promoter;

IH—intermittent hypoxia;

LDHA—lactate dehydrogenase A;

Lf—lactoferrin;

MPP+—1-methyl-4-phenylpyridine;

MPTP—1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine;

NFT—neurofibrillary tangles;

ODDD—oxygen-dependent degradation domain;

O-GlcNAc—O-linked N-acetylglucosamine;

OSA—obstructive sleep apnea;

PD—Parkinson’s disease;

PDK1—pyruvate dehydrogenase 1;

PHD—prolyl hydroxylase;

pVHL—von Hippel–Lindau protein;

ROS—reactive oxygen species;

sAPPβ—soluble APPβ;

SNc—compact part of the substantia nigra;

TH—tyrosine hydroxylase;

VEGFA—vascular endothelial growth factor A